BioGX's expanded flu/RSV test gets CE-IVD Mark October 23, 2019 -- BioGX announced that its new automated polymerase chain reaction test for influenza A, influenza B, and respiratory syncytial virus (RSV) has received the CE-IVD Mark.
Danaher divests lab business units to Sartorius for $750M October 21, 2019 -- Danaher is selling parts of its life science portfolio -- including its FortéBio label-free biomolecular characterization business -- to Sartorius for $750 million in cash to help satisfy regulatory requirements related to its acquisition of GE's biopharmaceutical business.
Ortho Sera extended blood typing clears FDA October 18, 2019 -- Ortho Clinical Diagnostics has announced the U.S. Food and Drug Administration (FDA) clearance of its Ortho Sera ID-Micro Typing System (MTS) extended antigen phenotyping in blood transfusion products, for use on the company's Ortho Vision analyzer.
Singapore sequencing project maps genes in Asians October 18, 2019 -- Whole-genome sequencing data for almost 5,000 people in Singapore were published on October 17 in the journal Cell, in what the researchers described as the largest genetic study of Asian populations in the world.
Invitae warns of false negatives on consumer tests October 18, 2019 -- Direct-to-consumer genetic tests that provide limited screening put people at risk for false-negative results, according to a study by Invitae presented at the American Society of Human Genetics annual meeting held October 15-19 in Houston.
NIH test inspects abnormal tau in cerebrospinal fluid October 17, 2019 -- A new test for abnormal tau in cerebrospinal fluid has potential for diagnosing a range of neurodegenerative conditions, researchers from the U.S. National Institutes of Health (NIH) concluded in a study published online October 16 in Acta Neuropathologica.